PPA
ANAC

Parametric Portfolio Associates’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Parametric Portfolio Associates’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-41,550
Closed -$2.22M – 4086
2016
Q1 		$2.22M Buy
41,550
+12,248
+42% +$904K ﹤0.01% 2309
2015
Q4 		$3.31M Buy
29,302
+2,301
+9% +$253K 0.01% 1774
2015
Q3 		$3.18M Buy
27,001
+8,003
+42% +$1.05M 0.01% 1482
2015
Q2 		$1.47M Buy
18,998
+6,618
+53% +$434K ﹤0.01% 2490
2015
Q1 		$716K Buy
12,380
+101
+0.8% +$4.29K ﹤0.01% 3038
2014
Q4 		$396K Buy
+12,279
New +$369K ﹤0.01% 3398

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Parametric Portfolio Associates's ANAC Position: Q2 2016 in Review

Parametric Portfolio Associates sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 41,550 shares — an estimated $2.22M sold.

Parametric Portfolio Associates first reported a position in ANAC in Q4 2014 and held it in 6 quarters. The position peaked at $3.31M in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Parametric Portfolio Associates reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Parametric Portfolio Associates sold 41,550 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $2.22M.
  • Parametric Portfolio Associates first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2014 and held it in 6 quarters.
  • Parametric Portfolio Associates's ANACOR PHARMACEUTICALS INC COM position peaked at $3.31M in Q4 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Parametric Portfolio Associates's 13F filing for Q2 2016, filed 12 Aug 2016.